Related Experiment Videos
Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide
C Majumdar1, C A Stein, J S Cohen
1Laboratory of Biochemistry, National Cancer Institute, Bethesda, Maryland 20892.
Biochemistry
|February 7, 1989
Summary
Investigating HIV reverse transcriptase, researchers found that phosphorothioate oligodeoxynucleotides like Sd(C)28 bind with high affinity, acting as potent competitive inhibitors of DNA synthesis.
Area of Science:
- Biochemistry
- Molecular Biology
- Virology
Background:
- Human Immunodeficiency Virus (HIV) reverse transcriptase is a key enzyme for viral replication.
- Understanding enzyme-primer interactions is crucial for developing antiviral therapies.
- Previous studies established an ordered reaction pathway for DNA synthesis by HIV reverse transcriptase.
Purpose of the Study:
- To investigate primer recognition by purified HIV reverse transcriptase.
- To characterize the inhibitory effects of oligodeoxynucleotides on DNA synthesis.
- To determine kinetic parameters of enzyme-primer interactions.
Main Methods:
- Enzyme kinetics studies using various template-primers.
- Competitive inhibition assays with d(C)28 and phosphorothioate oligodeoxynucleotide Sd(C)28.
- Filter binding assays to confirm enzyme-oligonucleotide binding affinity.
- Substrate kinetic studies to determine Km values.
Main Results:
- d(C)28 acts as a linear competitive inhibitor, binding to the free enzyme.
- Sd(C)28 demonstrates significantly higher affinity (lower Ki ≈ 2.8 nM) than d(C)28, indicating potent inhibition.
- Kinetic analysis revealed a Km of 24 nM for Sd(C)28 as a primer, with association and dissociation rate constants determined.
Conclusions:
- Phosphorothioate oligodeoxynucleotides, specifically Sd(C)28, are high-affinity binders and potent competitive inhibitors of HIV reverse transcriptase.
- The kinetic data provides insights into the real-time dynamics of enzyme-primer association and dissociation.
- These findings contribute to understanding HIV reverse transcriptase mechanisms and potential therapeutic targets.